SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-014891
Filing Date
2022-04-15
Accepted
2022-04-15 17:04:24
Documents
2
Period of Report
2022-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1665
2 EX-24 DOCUMENT attachment1.htm EX-24 4528
  Complete submission text file 0000899243-22-014891.txt   7706
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494
Business Address
Tyagarajan Seshu (Reporting) CIK: 0001923794 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40629 | Film No.: 22830546